TLCR Financial Facts

See Full Income Statement

See Full Balance Sheet

Talecris Biotherapeutics Holdings Corp. (TLCR) Earnings

  |   Expand Research on TLCR
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +8.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +8.0% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/27/11 Q111 $0.45$0.42 +$0.03$406.7M$409.55M N/A Details
2/23/11 Q410 $0.38$0.39 -$0.01$410.8M$413.84M N/A Details
10/28/10 Q310 $0.48$0.37 +$0.11N/AN/A N/A Details